|
1
|
Vargas HA, Martin-Malburet AG, Takeda T,
Corradi RB, Eastham J, Wibmer A, Sala E, Zelefsky MJ, Weber WA and
Hricak H: Localizing sites of disease in patients with rising serum
prostate-specific antigen up to 1 ng/ml following prostatectomy:
How much information can conventional imaging provide? Urol Oncol.
34:482.e5–482.e10. 2016. View Article : Google Scholar
|
|
2
|
Kane CJ, Amling CL, Johnstone PA, Pak N,
Lance RS, Thrasher JB, Foley JP, Riffenburgh RH and Moul JW:
Limited value of bone scintigraphy and computed tomography in
assessing biochemical failure after radical prostatectomy. Urology.
61:607–611. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stephenson AJ, Scardino PT, Kattan MW,
Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler
HM, Lin DW, et al: Predicting the outcome of salvage radiation
therapy for recurrent prostate cancer after radical prostatectomy.
J Clin Oncol. 25:2035–2041. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stish BJ, Pisansky TM, Harmsen WS, Davis
BJ, Tzou KS, Choo R and Buskirk SJ: Improved metastasis-free and
survival outcomes with early salvage radiotherapy in men with
detectable prostate-specific antigen after prostatectomy for
prostate cancer. J Clin Oncol. pii:JCO6834252016.(Epub ahead of
print).
|
|
5
|
Ceci F, Castellucci P, Graziani T,
Schiavina R, Chondrogiannis S, Bonfiglioli R, Costa S, Virgolini
IJ, Rubello D, Fanti S and Colletti PM: 11C-choline PET/CT
identifies osteoblastic and osteolytic lesions in patients with
metastatic prostate cancer. Clin Nucl Med. 40:e265–e270. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fanti S, Minozzi S, Castellucci P,
Balduzzi S, Herrmann K, Krause BJ, Oyen W and Chiti A: PET/CT with
(11)C-choline for evaluation of prostate cancer patients with
biochemical recurrence: Meta-analysis and critical review of
available data. Eur J Nucl Med Mol Imaging. 43:55–69. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sobol I, Zaid HB, Haloi R, Mynderse LA,
Froemming AT, Lowe VJ, Davis BJ, Kwon ED and Karnes RJ:
Contemporary mapping of post-prostatectomy prostate cancer relapse
with c-11-choline positron emission tomography and multiparametric
magnetic resonance imaging. J Urol. 197:129–134. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kjölhede H, Ahlgren G, Almquist H,
Liedberg F, Lyttkens K, Ohlsson T and Bratt O: (18)F-choline PET/CT
for early detection of metastases in biochemical recurrence
following radical prostatectomy. World J Urol. 33:1749–1752. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Castellucci P, Ceci F, Graziani T,
Schiavina R, Brunocilla E, Mazzarotto R, Pettinato C, Celli M, Lodi
F and Fanti S: Early biochemical relapse after radical
prostatectomy: Which prostate cancer patients may benefit from a
restaging 11C-Choline PET/CT scan before salvage radiation therapy?
J Nucl Med. 55:1424–1429. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Giovacchini G, Picchio M, Briganti A,
Cozzarini C, Scattoni V, Salonia A, Landoni C, Gianolli L, Di MN,
Rigatti P, et al: [11C]choline positron emission
tomography/computerized tomography to restage prostate cancer cases
with biochemical failure after radical prostatectomy and no disease
evidence on conventional imaging. J Urol. 184:938–943. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Giovacchini G, Picchio M, Garcia-Parra R,
Mapelli P, Briganti A, Montorsi F, Gianolli L and Messa C:
[11C]choline positron emission tomography/computerized tomography
for early detection of prostate cancer recurrence in patients with
low increasing prostate specific antigen. J Urol. 189:105–110.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Heidenreich A, Bastian PJ, Bellmunt J,
Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T,
Zattoni F, et al: EAU guidelines on prostate cancer Part 1
Screening, diagnosis, and local treatment with curative intent
update 2013. Eur Urol. 65:124–137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Afshar-Oromieh A, Avtzi E, Giesel FL,
Holland-Letz T, Linhart HG, Eder M, Eisenhut M, Boxler S, Hadaschik
BA, Kratochwil C, et al: The diagnostic value of PET/CT imaging
with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of
recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 42:197–209.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Eiber M, Maurer T, Souvatzoglou M, Beer
AJ, Ruffani A, Haller B, Graner FP, Kübler H, Haberhorn U, Eisenhut
M, et al: Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248
patients with biochemical recurrence after radical prostatectomy. J
Nucl Med. 56:668–674. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maurer T, Eiber M, Schwaiger M and
Gschwend JE: Current use of PSMA-PET in prostate cancer management.
Nat Rev Urol. 13:226–235. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Evangelista L, Briganti A, Fanti S, Joniau
S, Reske S, Schiavina R, Stief C, Thalmann GN and Picchio M: New
clinical indications for (18)F/(11)C-choline, new tracers for
positron emission tomography and a promising hybrid device for
prostate cancer staging: A systematic review of the literature. Eur
Urol. 70:161–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Perera M, Papa N, Christidis D, Wetherell
D, Hofman MS, Murphy DG, Bolton D and Lawrentschuk N: Sensitivity,
specificity and predictors of positive 68Ga-prostate-specific
membrane antigen positron emission tomography in advanced prostate
cancer: A systematic review and meta-analysis. Eur Urol.
70:926–937. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barentsz JO, Richenberg J, Clements R,
Choyke P, Verma S, Villeirs G, Rouviere O, Logager V and Futterer
JJ: European Society of Urogenital Radiology: ESUR prostate MR
guidelines 2012. Eur Radiol. 22:746–757. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Passoni NM, Suardi N, Abdollah F, Picchio
M, Giovacchini G, Messa C, Freschi M, Montorsi F and Briganti A:
Utility of [11C]choline PET/CT in guiding lesion-targeted salvage
therapies in patients with prostate cancer recurrence localized to
a single lymph node at imaging: Results from a pathologically
validated series. Urol Oncol. 32:38.e9–e16. 2014. View Article : Google Scholar
|
|
20
|
Afshar-Oromieh A, Zechmann CM, Malcher A,
Eder M, Eisenhut M, Linhart HG, Holland-Letz T, Hadaschik BA,
Giesel FL, Debus J and Haberkorn U: Comparison of PET imaging with
a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for
the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol
Imaging. 41:11–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bluemel C, Krebs M, Polat B, Linke F,
Eiber M, Samnick S, Lapa C, Lassmann M, Riedmiller H, Czernin J, et
al: 68Ga-PSMA-PET/CT in patients with biochemical prostate cancer
recurrence and negative 18F-Choline-PET/CT. Clin Nucl Med.
41:515–521. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schwenck J, Rempp H, Reischl G, Kruck S,
Stenzl A, Nikolaou K, Pfannenberg C and la Fougère C: Comparison of
68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate
cancer metastases by PET/CT. Eur J Nucl Med Mol Imaging.
44:92–101e. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis
CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D and de Vet
HC; STARD Group, : Towards complete and accurate reporting of
studies of diagnostic accuracy: The STARD initiative. Fam Pract.
21:4–10. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Freitag MT, Radtke JP, Hadaschik BA,
Kopp-Schneider A, Eder M, Kopka K, Haberkorn U, Roethke M,
Schlemmer HP and Afshar-Oromieh A: Comparison of hybrid (68)Ga-PSMA
PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and
bone metastases of prostate cancer. Eur J Nucl Med Mol Imaging.
43:70–83. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Demirkol MO, Acar O, Ucar B, Ramazanoglu
SR, Saglican Y and Esen T: Prostate-specific membrane antigen-based
imaging in prostate cancer: impact on clinical decision making
process. Prostate. 75:748–757. 2015. View Article : Google Scholar : PubMed/NCBI
|
